Novartis hands investors Alcon spin-off and $5bn share buyback
Eyecare business had been problematic since Novartis bought it for $52 billion in 2011
Novartis plans to buy back $5bn in stock over next two years
Pharma firm will expand in faster-growing areas of healthcare
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices